About 400 reports

Ado-trastuzumab emtansine (Kadcyla, ), an antibody that targets HER##, attaches itself to a chemo drug called Myotonic dystrophy type ## (DM##).

  • Chemotherapy
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group

ADCETRIS is a chimeric monoclonal immunoglobulin (Ig)G## antibody, which acts against CD## expressed in HL and systemic anaplastic large cell lymphoma.

  • Chemotherapy
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • DEMAND
  • IV. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND

The total sales volume of monoclonal antibody reached ## million Yuan in 2018.

  • Chemotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Kidney Cancer Treatment Drugs Sales Volume and Market Share by Drugs Classification in 2018 (Million Yuan/percent)
  • Kidney Cancer Treatment Drugs Sales Volume

Monoclonal antibodies are genetically engineered antibodies that are identical copies of one another.

  • Chemotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

THE COMPANY ALSO HAS SIX DRUGS IN PHASE II AND FIVE IN PHASE I FOR PROSTATE CANCER, WITH SMALL MOLECULES, MONOCLONAL ANTIBODIES (MABS), AND RADIOLABELLED AGENTS COVERING MULTIPLE MOAS.

  • Chemotherapy
  • East Asia
  • United States
  • Forecast
  • Pfizer Inc.
  • DEMAND
  • Liver Cancer Treatment Drugs Market Overview by Classification

Monoclonal antibodies are the six kinds of chemotherapy drugs and their sales volume increase annually.

  • Chemotherapy
  • China
  • Demand
  • Trade
  • Hainan Haiyao Company Limited

CRC. ##. ## Anti-angiogenesis Therapies ##. ##. ## AVASTIN (BEVACIZUMAB) - ROCHE Avastin is a recombinant, humanized, monoclonal immunoglobulin (IgG) ## antibody developed by Roche.

  • Chemotherapy
  • Colorectal Cancer
  • Therapy
  • Market Size
  • Merck & Co., Inc.
  • Liver Cancer Treatment Drugs Sales Volume by
  • DEMAND

Monoclonal antibodies are the six kinds of chemotherapy drugs and their sales volume increase annually.

  • Chemotherapy
  • China
  • Demand
  • Novartis AG
  • Sanofi-Synthelabo Inc.
  • Breast Cancer Therapeutics Market, Competitor Matrix for HER2-Positive Breast Cancer Marketed and Pipeline Products,

Distinct PD-L## binding characteristics of therapeutic monoclonal antibody durvalumab.

  • Cancer
  • Chemotherapy
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group
  • 9.3.4 TECENTRIQ (ATEZOLIZUMAB)

S KEYTRUDA IS A HUMANIZED ANTIBODY INHIBITING PD-##.

  • Chemotherapy
  • Hospital
  • United States
  • Forecast
  • PROVENGE group

PRESENCE IN CHEMOTHERAPY DRUGS MARKET COMPANY AT A GLANCE Bristol-Myer' s " Opdivo" is a human monoclonal antibody designed to overcome the immune suppression, that binds to the programmed death receptor-## (PD-##) on T and natural killer T (NKT) cells.

  • Chemotherapy
  • World
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Eli Lilly & Co.
  • Weakest performers
  • 2.8.2 CHEMOTHERAPY

s PD-## antibody Keytruda.

  • Chemotherapy
  • Cough And Cold
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.

To date, there have been three immune checkpoint-targeting monoclonal antibodies (mAbs) approved to treat SCLC.

  • Chemotherapy
  • Lung Cancer
  • Therapy
  • United States
  • Merck & Co., Inc.
  • PRODUCT PROFILE - SERIBANTUMAB (MM-121)
  • PRESENTS THE PRODUCT PROFILE FOR YERVOY.

ALTHOUGH THE DRUG FACES COMPETITION FROM ZYKADIA, ITS SUPERIOR SAFETY PROFILE IS EXPECTED TO GIVE IT AN ADVANTAGE OVER ZYKADIA. ##. ## PRODUCT PROFILES - MAJOR BRANDS, MONOCLONAL ANTIBODIES ##. ##. ## Programmed Cell Death Protein ##/ Programmed Death Ligand ## Immune P

  • Chemotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Overview of the Development Pipeline in HER2-Positive Breast Cancer
  • provides the primary completion dates of the active late-stage clinical trials for Perjeta.

Herceptin is a monoclonal antibody targeting the HER## receptor.

  • Chemotherapy
  • Company
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

Monoclonal antibodies urothelial cancer.

  • Chemotherapy
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 4.3 Molecular Targets in the Pipeline

Figure ##: Cancer Supportive Care Market, Global, Annual Revenue for Neulasta ($bn), 2011- ##. ## Xgeva (denosumab) - Amgen Xgeva (denosumab) is a human monoclonal antibody (mAb) approved in 2010 to help prevent skeletal-related events (SRE) in patients with cancer that had metastasize

  • Chemotherapy
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Insys Therapeutics, Inc.

Monoclonal antibody ENDPOINT RESULTS FOR DRUGS IN CHRONIC LYMPHOCYTIC LEUKAEMIA EXHIBIT ##: EFFICACY RESULTS FROM STUDY ## IN RELAPSED CHRONIC LYMPHOCYTIC LEUKAEMIA (##) DRUG: ZYDELIG/ IDELALISIB PFS: progression-free survival; NR: not reached The p value for PF

  • Chemotherapy
  • Leukemia
  • United States
  • Gilead Sciences, Inc.
  • Roche Group

Biopharmaceuticals such as monoclonal antibodies are different from small molecule drugs because of their biological nature.

  • Chemotherapy
  • Cough And Cold
  • China
  • Demand
  • Forecast
  • Capecitabine Major Producer and Their Market Share
  • Colon Cancer Treatment Drugs Sales Volume

Chart ##: Capecitabine Sales Volume and Market Share (million Yuan) Table ##: Capecitabine Major Producer and Their Market Share Chapter IV COLON CANCER TREATMENT DRUGS PRODUCTION AND DEMAND Bevacizumab is a monoclonal antibody that recognizes all vascular endothelial growth factor

  • Chemotherapy
  • China
  • Demand
  • Jiangsu Hengrui Pharmaceutical Co., Ltd
  • Roche Pharmaceutical Co., Ltd
  • PRODUCT PROFILE - TECENTRIQ
  • PRODUCT PROFILE - CYRAMZA

KEYTRUDA, A HUMANIZED ANTI-PD-## MONOCLONAL ANTIBODY, BINDS TO PD-## RECEPTORS AND BLOCKS THEM FROM THE INHIBITORY EFFECT OF PD-## LIGANDS, PROMOTING A T-CELL RESPONSE.

  • Chemotherapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

The project of I## labeled hepatocarcinoma monoclonal antibody injection, cooperated with the Fourth Military Medical University, has now completed clinical phase study.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

The project of I## labeled hepatocarcinoma monoclonal antibody injection, cooperated with the Fourth Military Medical University, has now completed clinical phase study.

  • Chemotherapy
  • China
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • Shenzhen Main Luck Pharmaceuticals Inc.

There are many kinds of high-technology products including cell engineering, genetic engineering, biological ferment, monoclonal Chapter VII BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY antibody and protein purification etc.

  • Chemotherapy
  • China
  • Demand
  • Trade
  • Sanofi-Synthelabo Inc.
  • Capecitabine Major Producer and Their Market Share
  • Colon Cancer Treatment Drugs Sales Volume

Chart ##: Capecitabine Sales Volume and Market Share (million Yuan) Table ##: Capecitabine Major Producer and Their Market Share Chapter IV COLON CANCER TREATMENT DRUGS PRODUCTION AND DEMAND Bevacizumab is a monoclonal antibody that recognizes all vascular endothelial growth factor

  • Chemotherapy
  • China
  • Jiangsu Hengrui Pharmaceutical Co., Ltd
  • Roche Pharmaceutical Co., Ltd
  • Zhejiang Wanma Pharmaceutical Co., Ltd

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Chemotherapy
  • Cough And Cold
  • China
  • Demand
  • Trade
  • LEADING TREATMENTS FOR HNCS
  • KEYTRUDA SWOT ANALYSIS

AZ' S IMFINI IS A HUMANIZED MONOCLONAL ANTIBODY AGAINST PD-L##.

  • Chemotherapy
  • Cough And Cold
  • Japan
  • United States
  • Merck & Co., Inc.

The project of I## labeled hepatocarcinoma monoclonal antibody injection, cooperated with the Fourth Military Medical University, has now completed clinical phase study.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

The project of I## labeled hepatocarcinoma monoclonal antibody injection, cooperated with the Fourth Military Medical University, has now completed clinical phase study.

  • Chemotherapy
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd
  • 3.1 Overview

Relationship between PD-L## expression and clinical outcomes in patients with advanced gastric cancer treated with the anti-PD-## monoclonal antibody pembrolizumab (MK-##) in KEYNOTE-##.

  • Chemotherapy
  • Monoclonal Antibody
  • Market Size
  • AstraZeneca PLC
  • Roche Group